Vericel Corporation Cash Conversion Cycle 2011-2025 | VCEL

Annual Cash Conversion Cycle Vericel Corporation

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
48	66.9	105	109	112	104	53.9	83.2	75.4	-7.73	21.4	-215 K	-172 K	-204 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
112	-215 K	-42.2 K

Quarterly Cash Conversion Cycle Vericel Corporation

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
102	96.4	82	-	32.6	38.8	53	-	69.1	86.8	105	-	70.1	60.6	127	-	125	93.1	100	69.6	122	185	128	74.5	101	117	100	68.3	95.2	113	106	71.4	117	98.3	172	94.4	143	122	90.6	64.6	88.1	73.3	80.4	50.8	77.4	169	-	-	-	122	160	88.8	411	456	456	-	91.2	91.2	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
456	32.6	118

Cash Conversion Cycle of other stocks in the Biotechnology industry

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
Arbutus Biopharma Corporation ABUS	31.5	$ 4.89	3.82 %	$ 812 M	Canada
Aclaris Therapeutics ACRS	-881	$ 3.22	-1.08 %	$ 249 M	USA
Aptevo Therapeutics APVO	-47.4	$ 1.07	-5.31 %	$ 295 K	USA
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	17	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	82.8	-	-18.52 %	$ 27.3 M	Britain
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
Adaptimmune Therapeutics plc ADAP	25	-	-15.15 %	$ 60.3 M	Britain
Albireo Pharma ALBO	-1.55 K	-	-0.23 %	$ 916 M	USA
Alpine Immune Sciences ALPN	154	-	-	$ 2.17 B	USA
Ampio Pharmaceuticals AMPE	-2.85 K	-	-11.43 %	$ 502 K	USA
Amphastar Pharmaceuticals AMPH	166	$ 26.35	4.25 %	$ 1.28 B	USA
Anika Therapeutics ANIK	270	$ 9.62	0.63 %	$ 141 M	USA
Catalyst Biosciences CBIO	391	$ 13.28	-5.78 %	$ 874 M	USA
Arena Pharmaceuticals ARNA	946	-	-6.81 %	$ 3.04 B	USA
Axon Enterprise AXON	86.2	$ 550.6	-2.43 %	$ 41.7 B	USA
Ayala Pharmaceuticals AYLA	-2.15 K	-	-	$ 7.46 M	Israel
Aytu BioScience AYTU	174	$ 2.37	3.04 %	$ 14.9 M	USA
AstraZeneca PLC AZN	-58	$ 91.34	1.68 %	$ 96.9 B	Britain
Celldex Therapeutics CLDX	-6.08 K	$ 27.0	-1.85 %	$ 1.74 M	USA
Acorda Therapeutics ACOR	117	-	-24.86 %	$ 820 K	USA
Brickell Biotech BBI	149	-	-5.38 %	$ 6.06 M	USA
BeiGene, Ltd. BGNE	49.5	-	0.49 %	$ 251 B	Cayman-islands
Biohaven Pharmaceutical Holding Company Ltd. BHVN	209	$ 11.3	-2.04 %	$ 731 M	USA
Biogen BIIB	387	$ 175.09	0.57 %	$ 25.5 B	USA
Abeona Therapeutics ABEO	387	$ 5.07	-5.5 %	$ 108 M	USA
Corcept Therapeutics Incorporated CORT	-186	$ 87.9	-0.1 %	$ 9.07 B	USA
Catalyst Pharmaceuticals CPRX	54.2	$ 24.31	2.92 %	$ 2.88 B	USA
ADiTx Therapeutics ADTX	-4.31 K	$ 1.6	-28.57 %	$ 21.1 K	USA
Bellicum Pharmaceuticals BLCM	6.09	-	-9.72 %	$ 5.89 M	USA
Berkeley Lights BLI	214	-	-7.31 %	$ 87 M	USA
Advaxis ADXS	-143 K	-	-9.65 %	$ 45.9 M	USA